Angel Nova 3.4 oz EDP Refillable for Women

Angel Nova 3.4 oz EDP Refillable for Women

Marsoni

M251S

$104.00

Get it in 3 business days with 1 day shipping. Friday, May 29

Angel Nova 3.4 oz EDP Refillable for WomenAngel Nova is a bold and modern fragrance that blends fruity sweetness with a powerful floral heart. It opens with a vibrant burst of juicy raspberry and litchi, creating a bright and addictive first impression. The heart reveals a rich and elegant rose, adding depth and feminine sophistication. As it settles, warm woody notes like akigalawood and benzoin create a smooth, long lasting, and confident trail. Perfect for both day and evening wear, it

Easy Shipping

Quick Dispatch:

Your Angel Nova 3.4 oz EDP Refillable for Women orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your Angel Nova 3.4 oz EDP Refillable for Women ships.

Need Help?
Questions about Angel Nova 3.4 oz EDP Refillable for Women, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Angel Nova 3.4 oz EDP Refillable for Women in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

All of these Cole Haan shoes are extremely well made and I like the styling. On the other hand, the sizing is very inconsistent and you may end up having to do a lot of returns trying to find the right size. Then if you get a different color of it, you may find the sizing different yet again. If you find your right zie, they are really nice shoes at a very reasonable price for the quality.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on February 6, 2026